HARRISBURG (NewsRadio 1020 KDKA) — Pennsylvania will receive more than $3.8 million from a settlement for deceptive marketing of transvaginal mesh.
Johnson & Johnson and its subsidiary Ethicon, Inc. will pay nearly $117 million to 41 states and the District of Columbia after misrepresenting the safety and efficacy of the devices.
The synthetic surgical mesh is implanted to support pelvic organs to treat incontinence or prolapse. It can cause several painful side effects including chronic pain and inflammation, scarring and painful intercourse.
Evidence shows Johnson and Johnson knew these risks and did not properly disclose them.